Master Alliance Provisions Guide (MAPGuide)

UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement

  • Term & termination | Effects of termination
  • Term & termination | Termination & withdrawal



2. This Agreement may be terminated on thirty (30) days’ written notice by either party if the other party:

(a) fails to make any payment to the other party when due; or

(b) breaches the terms of this Agreement (and, where the breach is capable of remedy, has not remedied the breach within thirty (30) days of receiving notice requiring the breach to be remedied); or

(c) persistently breaches the Agreement; or

(d) suffers a material event of insolvency.

3. This Agreement may be terminated immediately on written notice by either party on the recommendation of the Independent Data Monitoring Committee.


8. When the Programme is completed or is terminated prior to completion the Centres shall arrange either (at Indevus’s election) for the destruction (without cost to Indevus) or return to Indevus (at Indevus’s cost) of any unused Product and matching placebo in accordance with the Protocol and all applicable legal requirements and the requirements of any relevant regulatory authorities.